Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.000001 0 (0%) Market Cap: - Enterprise Value: -17.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Infinity Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 05:00PM GMT
Release Date Price: $1.19
Anupam Rama
JP Morgan Chase & Co, Research Division - VP and Analyst

This is the Thursday morning of the 2020 JPMorgan Healthcare Conference. Welcome, everyone. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team. Our next presenting company is Infinity. And presenting on behalf of the company is CEO, Adelene Perkins. Adelene?

Adelene Q. Perkins
Infinity Pharmaceuticals, Inc. - Chairman & CEO

Thank you, Anupam. Thank you to JPMorgan for inviting us to present. I appreciate all of you coming this morning, and welcome to those who are participating via the webcast to learn about IPI-549, which targets immune suppressive macrophages to improve immunotherapies. And we are now in studies in over 500 patients.

I'll remind you that I'll be making forward-looking statements this morning, which you can review in more detail in our most recent 10-Q. The most important thing for you to know about Infinity and IPI-549 is that we have 5 studies that are reading out

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot